T1	Parameter 1794 1805	RAFWT cells
T2	Parameter 1844 1853	Cmpds A-G
T3	Parameter 1894 1903	BRAFV600E
T4	DepVb 1944 1952	activity
T7	Parameter 1990 2004	SW620 (BRAFWT)
T5	Parameter 1961 1985	A375 (BRAFV600E mutated)
T6	DepVb 2005 2015	cell lines
T8	Parameter 2165 2176	SW620 cells
T9	IndepVb 2233 2259	maximal pathway activation
T10	Measurement 2273 2300	low compound concentrations
T11	Measurement 2305 2330	modest pathway inhibition
T12	Parameter 2334 2360	the highest concentrations
T14	DepVb 2460 2476	compound potency
T15	IndepVb 2481 2495	MAPK induction
T16	Parameter 2499 2504	SW620
T17	DepVb 2526 2589	compound inhibition half-maximal effective concentration (EC50)
T18	Parameter 2600 2604	A375
T19	Parameter 2652 2658	Cmpd A
T20	Parameter 2663 2669	Cmpd B
T21	Parameter 2700 2734	the lowest concentrations in SW620
T13	DepVb 2788 2794	growth
T22	Parameter 2798 2807	BRAFV600E
T23	Parameter 2838 2844	BRAFWT
T24	DepVb 2828 2834	growth
T25	Parameter 2757 2781	catalytic RAF inhibitors
T26	Parameter 3228 3241	RAF compounds
T27	DepVb 3265 3273	activity
T28	Parameter 3291 3335	BRAFV600E, BRAFWT, and CRAFWT kinase domains
T29	Parameter 3359 3368	BRAFV600E
T30	Parameter 3466 3502	a subphysiological ATP concentration
T31	Parameter 3430 3436	BRAFWT
T32	Parameter 3441 3453	CRAF enzymes
T33	IndepVb 3406 3414	compound
T34	Parameter 3566 3572	BRAFWT
T35	Parameter 3577 3581	CRAF
T36	Parameter 3585 3617	physiological ATP concentrations
T37	DepVb 3627 3646	MEK phosphorylation
T38	Statistical-Effect 3652 3667	biphasic manner
T40	DepVb 3923 3937	basal activity
T39	IndepVb 3877 3904	cellular ATP concentrations
T41	Parameter 3908 3914	1-5 mM
T42	Parameter 3946 3960	RAFWT isoforms
T43	Measurement 3965 3983	greatly diminished
T44	Parameter 4000 4009	BRAFV600E
T45	Measurement 4017 4035	increased activity
T46	Parameter 4039 4043	1 mM
T47	IndepVb 4044 4047	ATP
T48	DepVb 4119 4135	compound potency
T49	Parameter 4140 4146	BRAFWT
T50	Parameter 4151 4155	CRAF
T51	IndepVb 4140 4167	BRAFWT and CRAF stimulation
T52	Statistical-Effect 4168 4183	correlated with
T53	DepVb 4184 4237	compound half-maximal inhibitory concentration (IC50)
T54	Parameter 4242 4251	BRAFV600E
T55	IndepVb 4242 4262	BRAFV600E inhibition
T61	Parameter 4514 4520	BRAFWT
T62	Parameter 4525 4529	CRAF
T60	DepVb 4487 4529	basal kinase activities of BRAFWT and CRAF
T63	Parameter 4535 4545	diminished
T64	Parameter 4549 4581	physiological ATP concentrations
T65	Statistical-Effect 4602 4650	kinetic differences between BRAFV600E and BRAFWT
T56	Measurement 4678 4696	a maximum velocity
T57	Parameter 4729 4734	44 μM
T58	DepVb 4715 4725	Km(ATP)app
T59	DepVb 4736 4762	initial rates of catalysis
T66	Parameter 4767 4773	BRAFWT
T67	Parameter 4778 4782	CRAF
T68	Parameter 4788 4808	dramatically reduced
T69	DepVb 4812 4830	ATP concentrations
T70	Parameter 4837 4842	40 μM
T71	DepVb 4849 4868	The catalytic rates
T72	Parameter 4877 4887	WT enzymes
T73	DepVb 4965 4975	Km(ATP)app
T74	DepVb 5175 5199	wild-type RAF constructs
T75	Parameter 5212 5223	inactivated
T76	Parameter 5227 5253	high concentrations of ATP
T77	Parameter 5265 5309	BRAF kinase domain isolated to a single band
T78	DepVb 5380 5406	the initial enzymatic rate
T79	DepVb 5435 5449	concentrations
T80	Parameter 5462 5472	100 μM ATP
T81	DepVb 5486 5511	the catalytic rate change
T82	Parameter 5534 5540	BRAFWT
T83	Parameter 5545 5549	CRAF
T84	Parameter 5558 5568	0.5 μM ATP
T85	Parameter 5641 5694	concentrations below the observed initial rate change
T86	Parameter 5702 5711	40 μM ATP
T87	DepVb 5717 5728	rate change
T88	Parameter 5738 5744	faster
T89	Parameter 5748 5761	ATP increased
T90	Parameter 5770 5790	nearly instantaneous
T91	Parameter 5794 5827	the highest concentrations of ATP
T92	DepVb 5837 5872	the observed initial enzymatic rate
T93	Parameter 5883 5893	diminished
T94	DepVb 1876 1885	potencies
T95	IndepVb 2183 2191	compound
T96	Parameter 2202 2205	ERK
T99	Parameter 2622 2631	BRAFV600E
T100	Measurement 2606 2642	the most potent BRAFV600E inhibitors
T101	Parameter 2646 2650	A375
T102	IndepVb 2798 2813	BRAFV600E cells
T104	IndepVb 3232 3241	compounds
T105	IndepVb 3321 3335	kinase domains
T106	DepVb 3369 3384	phosphorylation
T107	Parameter 3337 3350	All compounds
T108	Statistical-Effect 3351 3358	blocked
T109	Parameter 3388 3391	MEK
R1	parameterizes Arg1:T29 Arg2:T108	
R2	measures Arg1:T108 Arg2:T106	
R3	parameterizes Arg1:T109 Arg2:T108	
R4	parameterizes Arg1:T107 Arg2:T108	
T110	Statistical-Effect 3420 3429	inhibited
T97	Statistical-Effect 2209 2227	a biphasic pattern
T98	Statistical-Effect 2505 2520	correlated well
T103	Statistical-Effect 2671 2679	activate
T111	Parameter 2680 2696	the MAPK pathway
T112	IndepVb 3554 3562	compound
R5	measures Arg1:T43 Arg2:T40	
R6	measures Arg1:T41 Arg2:T39	
R7	parameterizes Arg1:T41 Arg2:T43	
R8	parameterizes Arg1:T42 Arg2:T43	
R9	parameterizes Arg1:T44 Arg2:T43	
R10	measures Arg1:T45 Arg2:T40	
R11	parameterizes Arg1:T46 Arg2:T45	
R12	measures Arg1:T46 Arg2:T47	
R15	measures Arg1:T52 Arg2:T48	
R16	measures Arg1:T52 Arg2:T53	
R13	parameterizes Arg1:T51 Arg2:T48	
R14	parameterizes Arg1:T55 Arg2:T53	
